RE:FredZarfloon your are are brownRocketred2015 wrote:
your so full of chit it stinks in the room
what did he say that was wrong....the link he posted was from february, but as of last week, check the article below. Either way this doesnt look good. You have to be wary in all situations.
9:08AM ET on Friday Jun 08, 2018 by MT Newswires
09:08 AM EDT, 06/08/2018 (MT Newswires) -- Immune Pharmaceuticals (IMNP), a biopharmaceutical company, said pre-market Friday that it has received a letter from the listing qualifications department of the Nasdaq Stock Market.
The letter indicates that Immune's failure to regain compliance with the minimum $1.00 bid price requirement by May 30 could serve as a basis for the delisting of the company's shares from the Nasdaq Capital Market unless the company makes a timely request for a hearing before the Nasdaq hearings panel.
The company said it plans to request a hearing before the panel, when it said it will will present its plan to show compliance with the bid price requirement and request an extension of time within which to do so.
Immune said it continues to execute its strategic plan for the development of its core assets, and it continues to actively explore strategic options with respect to its oncology and other non-core assets.
Shares closed at $0.2349 on Thursday, up 0.4% on the day.
Price: 0.2349, Change: +0.0009, Percent Change: +0.38